<http://www.poz.com>
POZ E-mail Update
Tuesday, February 6, 2007


February 5, 2007

Chinese AIDS Activist Under House Arrest
<http://www.poz.com/articles/1_11227.shtml>

Another Benefit of HIV Disclosure?
<http://www.poz.com/articles/1_11228.shtml>

Crystal Meth Use Falls <http://www.poz.com/articles/1_11229.shtml>


February 2, 2007

Drug-Resistant Strain in Seattle
<http://www.poz.com/articles/1_11222.shtml>

On the Road With HIV in India
<http://www.poz.com/articles/1_11223.shtml>

HIV On the Ups Down Under <http://www.poz.com/articles/1_11224.shtml>

Call Now! Fight AIDS in D.C.
<http://www.poz.com/articles/1_11225.shtml>

Hep C: Heavy Drinking Riskier for Women than Men
<http://www.poz.com/articles/761_11217.shtml>
Heavy alcohol use increases mortality with hepatitis C to a greater
extent in female patients than in males, according to a report in the
February issue of Alcoholism: Clinical and Experimental Research.

HIV Rates Drop Among Florida Blacks
<http://www.poz.com/articles/761_11218.shtml>
Between 1999 and 2004, the rates of new HIV/AIDS diagnoses declined
among blacks living in Florida, according to a report by investigators
at the Florida Department of Health and the Centers for Disease
Control and Prevention. The annual rate of decline was significantly
greater than for other racial/ethnic groups.


February 1, 2007

Democrats Are in the House
<http://www.poz.com/articles/1_11213.shtml>

Bulgaria Charges Torture <http://www.poz.com/articles/1_11214.shtml>

High Rates of Dementia in Africa
<http://www.poz.com/articles/1_11215.shtml>

Asthma Med for IRIS? <http://www.poz.com/articles/761_11207.shtml>
Doctors in London have reported encouraging results using a common
asthma medication to treat an HIV-positive man with immune
reconstitution inflammatory syndrome (IRIS). The case report,
published in the January 30 issue of AIDS, suggests that the
patients rapid recovery upon starting treatment with the leukotriene
inhibitor montelukast (Singulair) may also provide important
information about the mechanisms responsible for IRIS seen in many
HIV-positive people receiving antiretroviral therapy.

Despite Setback, Advocates Push for Continued Microbicide Research
<http://www.poz.com/articles/761_11208.shtml>
HIV prevention advocates are emphasizing the importance of continued
research into new HIV prevention options, despite the recent
discontinuation of the Phase III effectiveness trials of the
microbicide candidate, cellulose sulfate (CS).


Copyright 2007 Smart + Strong, 500 Fifth Avenue, Suite 320, New York,
NY 10110. All rights reserved.